News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
213 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17909)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
RedHill Biopharma Reports 2017 Third Quarter Financial Results
RedHill maintains a debt-free balance sheet with $39.6 million in cash1 at the end of the third quarter of 2017.
November 13, 2017
·
31 min read
First Meeting of Health and Biosciences Economic Strategy Table Identifies Canada With Potential to be Global Economic Powerhouse
Karimah Es Sabar, CEO and Partner, Quark Venture, chaired the first Health and Biosciences Economic Strategy Table meeting in Vancouver, on November 9, 2017.
November 13, 2017
·
3 min read
Pharm Country
Creative Peptides Newly Diversified Its Special Antigen Peptides Services
On October 26, 2017, the leading peptides supplier Creative Peptides announced to further diversify its special antigen peptides services after entering this market for nearly a decade.
November 13, 2017
·
1 min read
Genetown
Spero Therapeutics Announces Underwriters’ Option Exercise
Spero’s common stock began trading on The Nasdaq Global Select Market on November 2, 2017 under the symbol “SPRO”.
November 13, 2017
·
2 min read
ARCEDI Biotech Announces Launch of First and Only Non-Invasive Prenatal Testing Based on Fetal Cells in Maternal Blood In Denmark
ARCEDI Biotech ApS today announced that the Company’s non-invasive prenatal testing technology based on fetal cells enriched from maternal blood will be implemented at hospitals within the Central Denmark region and further holds potential for worldwide implementation.
November 13, 2017
·
4 min read
Business
Rexgenero Announces the Appointment of Sam MacHour to its Scientific Advisory Board
Rexgenero is pleased to announce today the appointment of Sam MacHour to its SAB.
November 13, 2017
·
2 min read
Business
Leap Therapeutics Reports Third Quarter 2017 Financial Results and Announces First Patient Dosed with DKN-01 and KEYTRUDA (pembrolizumab) in Esophagogastric Cancer Trial
Net loss was $6.8 million for the third quarter of 2017, compared to $7.3 million for the same period in 2016.
November 13, 2017
·
11 min read
BioMidwest
3M Announces Upcoming Investor Events
These events will be webcast live, and replays of each will be available on 3M’s Investor Relations website at http://investors.3M.com.
November 13, 2017
·
1 min read
Inventiva to Present at Two Upcoming Investor Conferences
Inventiva today announced that Frédéric Cren, CEO of Inventiva, will present at two upcoming investor conferences.
November 13, 2017
·
2 min read
Business
CARMAT Signs a Partnership Agreement With AddUp, the Michelin and Fives Joint Venture Specialized in 3D Printing
CARMAT today announces that it has signed a partnership agreement with AddUp, the Joint Venture specialized in 3D printing set up by the Michelin and Fives groups.
November 13, 2017
·
5 min read
Previous
21 of 22
Next